11/17/2021: Lab Advisory: FDA Updates COVID-19 Testing Policies

CDC's Laboratory Outreach Communication System (LOCS)

Audience: Individuals Performing COVID-19 Testing

Level: Laboratory Advisory

On November 15, 2021, the U.S. Food and Drug Administration (FDA) issued a news release about actions the agency is taking to support ongoing COVID-19 testing efforts across the country. These actions will help ensure the accuracy and reliability of COVID-19 tests, including Laboratory Developed Tests. Updated FDA policies aim to increase access to self-tests and point-of-care tests that do not have to be sent to a central laboratory.

View the FDA news release for more information.

Please share this message with your networks and invite them to opt in to LOCS to receive future updates.

Online resources:

Questions?

Thank you,

The Laboratory Outreach Communication System

Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)

Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)

Centers for Disease Control and Prevention (CDC)

LOCS@cdc.gov

www.cdc.gov/csels/dls/locs

Page last reviewed: November 17, 2021